ALOX15 and neoplasm: In conclusion, our findings support the concept that 15-LOX-1 expression loss in cancer cells promotes not only early stages but also late stages of tumorigenesis, including hypoxia-driven selection of a metastatic phenotype that promotes tumor cell survival, invasion, migration, and ability to modulate the microenvironment via angiogenesis.